“But a new automated tool embedded in the electronic health record...
Category:
Health
Latest
Patients who recognise their symptoms of heart attack are less likely to die in hospital
"The findings indicate that education is needed for the general...
One billion people globally to have osteoarthritis by 2050: Lancet Study
Obesity or high body mass index (BMI) was an important risk factor...
PM Modi chairs high-level meet to review COVID situation as cases surge
India on Sunday recorded 93,249 new coronavirus infections, the highest single-day rise so far this year, which took the total COVID-19 cases to 1,24,85,509, according to Union health ministry data.
This is the biggest daily rise in cases since September 19, when 93,337 fresh infections were recorded.
Maharashtra announces stringent COVID-19 restrictions from Monday
The state, which includes the financial capital Mumbai, will shut down malls, cinemas, bars, restaurants and places of worship from Monday evening. Authorities will also impose a complete lockdown on weekends, Nawab Malik, a minister in the state government, told reporters after a cabinet meeting
6.1 million Indians among over 533 million users suffer Facebook data leak
“All 533,000,000 Facebook records were just leaked for free. This means that if you have a Facebook account, it is extremely likely the phone number used for the account was leaked,” tweeted Alon Gal, CTO of security firm Hudson Rock.
“I have yet to see Facebook acknowledging this absolute negligence of your data,” he added.
Facebook has confirmed the leak to The Record.
30 cases of blood clots in UK after AstraZeneca vaccine jab against Covid-19
Earlier in mid-March, the country had reported about only five thrombosis cases following usage of AstraZeneca vaccines, the agency further said.
The European Medicines Agency’s (EMA) committee, a couple of weeks earlier, had announced that the AstraZeneca coronavirus vaccine is “safe and effective” against Covid-19.
Experts disapprove using Chinese vaccine Sinopharm on Sri Lankans: Report
“We are also aware that in their report dated March 17, 2021, that the panel concluded that there is insufficient data provided to make a determination on the safety, efficacy and immunogenicity of the Sinopharm vaccine. This observation was made after reviewing all data made available by the manufacturer of the vaccine. It was accordingly concluded that the Sinopharm vaccine should not be used in Sri Lanka under the present circumstances,” the statement read.
Study finds new risk factors linked to increased risk of Covid-19 infection
“Certain baseline cardiometabolic factors appear to either protect a person from Covid-19 infection while others make a person more vulnerable to infection,” said study author Charles Hong, MD, PhD, professor of medicine and director of cardiology research at the University of Medicine School of Medicine.
Two +ve tests at interval of 102 days with one -ve defined as SARS-CoV-2 re-infection: ICMR study
Currently, there is no consensus regarding the working definition of re-infection, based only on epidemiological features; a resource intensive method like whole genome sequencing being the only confirmation.
Cybercriminal hacks vaccine marketplace, makes over $752K
The researchers found that the dark net advertisements for Covid-19 vaccines have increased by over 300 per cent in the past three months.
The Covid vaccine sellers are majorly based in the US and European countries including Spain, Germany, France and Russia.
India’s daily coronavirus infections almost touch 90,000
Eight states witnessed a steep rise in daily new COVID-19 cases and accounted for 81.42 per cent of the infections reported on Saturday, the Union Health Ministry said.
These eight states are Maharashtra, Karnataka, Chhattisgarh, Delhi, Tamil Nadu, Uttar Pradesh, Punjab and Madhya Pradesh.
US: Johnson & Johnson begins testing Covid-19 vaccines on teenagers
The study is testing the safety and efficacy of both one-dose and two-dose regimens of the vaccine, with the two-dose regimens being studied at intervals of one, two and three months after the first shot.